
927 articles by Nick Paul Taylor
-
NuVasive buys Simplify Medical in play for $2.6B cervical spine market
Feb. 26, 2021 -
Axonics adds incontinence device to portfolio in $200M Contura takeover
Feb. 26, 2021 -
UK industry pushes for pre- and post-vaccination roles for COVID-19 antibody tests
Feb. 25, 2021 -
Nevro predicts resurgent pain implant sales in 2021 after slow start to the year
Feb. 25, 2021 -
ACLA urges Biden to fund uninsured COVID-19 testing, close coverage loopholes
Feb. 24, 2021 -
UK adopts medical device legislation, setting stage for new databases and sanctions
Feb. 24, 2021 -
FDA lays path to weigh virus variant impact on COVID-19 test results
Feb. 23, 2021 -
FDA starts review of how skin pigmentation affects pulse oximeter results
Feb. 22, 2021 -
Boston Scientific's ICD recall gets 2nd Class I label from FDA
Feb. 22, 2021 -
Quidel mulls entering new COVID-19 testing markets after another bumper quarter
Feb. 19, 2021 -
Smith & Nephew Q4 knee sales plummet, exceeding drops reported by Stryker and Zimmer Biomet
Feb. 18, 2021 -
FDA approves 3D-printed ankle implant for humanitarian use
Feb. 18, 2021 -
Exact Sciences-Guardant rivalry in colorectal testing market heats up
Feb. 17, 2021 -
FDA admits COVID-19 antibody test policy was 'flawed,' offers lessons for future outbreaks
Feb. 16, 2021 -
In run-up to MDR, EU posts guide to legacy devices in Eudamed
Feb. 15, 2021 -
Abbott, Medtronic could benefit as spinal cord stim seen rebounding
Feb. 12, 2021 -
LabCorp warns COVID-19 testing sales could plummet as crisis abates
Feb. 11, 2021 -
Qiagen shuns M&A that 'dilutes' its focus amid reports of Quidel merger
Feb. 10, 2021 -
Heart disease devices lead latest batch of FDA breakthrough nods
Feb. 10, 2021 -
Medicare DME competitive bidding in doubt after failed round: analysts
Feb. 8, 2021 -
FDA OKs Signifier neurostim device for snoring, sleep apnea
Feb. 8, 2021 -
Abbott antigen test cuts in-school COVID-19 infections in pilot study, but raises challenges
Feb. 5, 2021 -
Roche diagnostics revenues up 28% fueled by COVID-19 antigen test demand
Feb. 4, 2021 -
PerkinElmer predicts sharp falloff in COVID-19 sales this year
Feb. 3, 2021 -
Death, injuries prompt FDA to call Boston Scientific ICD recall Class I event
Feb. 3, 2021